Theranexus Société Anonyme (ALTHX.PA)

1.1200 0.0000 (0.00%) At close: 04:08PM CEST

Theranexus Société Anonyme

60, Avenue Rockefeller
Laennec Nursery
Lyon 69008
France
33 1 88 89 70 31
https://www.theranexus.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 19

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Franck Mouthon	Co-Founder & Executive Chairman	285.4k	N/A	N/A
Mr. Mathieu Charvériat	Co-Founder, CEO & Director	251.77k	N/A	N/A
Mr. Thierry Lambert	CFO and Administrative & Financial Director	N/A	N/A	1954
Ms. Francoise Vincent-Larrode	Director of Human Resources	N/A	N/A	N/A
Mr. Julien Veys	Chief Business Officer & Director	N/A	N/A	N/A
Ms. Marie Sebille	Chief Medical Officer	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Theranexus Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders. It is involved in the development of Batten-1, an initial drug candidate currently under Phase ½ clinical study for Batten disease. The company was founded in 2013 and is headquartered in Lyon, France.

Corporate governance

Theranexus Société Anonyme’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.